Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
34.14 USD | +1.79% | +4.09% | +53.30% |
02/05 | Agios Pharmaceuticals Shares Rise After Reporting Smaller Q1 Loss | MT |
02/05 | Transcript : Agios Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 02, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+53.30% | 190.42Cr | |
+5.33% | 11TCr | |
+12.11% | 11TCr | |
-12.56% | 2.23TCr | |
-3.70% | 2.19TCr | |
-6.03% | 1.86TCr | |
-35.21% | 1.81TCr | |
-10.86% | 1.7TCr | |
+5.10% | 1.37TCr | |
+37.57% | 1.24TCr |
- Stock Market
- Equities
- AGIO Stock
- News Agios Pharmaceuticals, Inc.
- RBC Cuts Price Target on Agios Pharmaceuticals to $44 From $48, Maintains Outperform Rating